Aztreonam

In the US, Aztreonam (aztreonam systemic) is a member of the drug class miscellaneous antibiotics and is used to treat Bacteremia, Bacterial Infection, Bone infection, Cystic Fibrosis, Febrile Neutropenia, Intraabdominal Infection, Kidney Infections, Pelvic Inflammatory Disease, Peritonitis, Pneumonia, Pneumonia with Cystic Fibrosis, Skin and Structure Infection, Skin Infection and Urinary Tract Infection.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J01DF01

CAS registry number (Chemical Abstracts Service)

0078110-38-0

Chemical Formula

C13-H17-N5-O8-S2

Molecular Weight

435

Therapeutic Category

Antibacterial: Monobactam

Chemical Name

Propanoic acid, 2-[[[1-(2-amino-4-thiazolyl)-2-[(2-methyl-4-oxo-1-sulfo-3-azetidinyl)amino]-2-oxoethylidene]amino]oxy]-2-methyl-, [2S-[2α,3β(Z)]]-

Foreign Names

  • Aztreonamum (Latin)
  • Aztreonam (German)
  • Aztréonam (French)
  • Aztreonam (Spanish)

Generic Names

  • Aztreonam (OS: DCIT, USAN, BAN)
  • Aztréonam (OS: DCF)
  • SQ 26776 (IS: Squibb)
  • Aztreonam (PH: JP XV, USP 34)
  • Aztreonam Lysine (OS: USAN)
  • Corus1020 (IS)
  • UNII-XNM7LT65NP (IS)

Brand Names

  • Azactam
    Bristol Myers Squibb, Spain; Bristol-Myers Squibb, Austria; Bristol-Myers Squibb, Australia; Bristol-Myers Squibb, Belgium; Bristol-Myers Squibb, Bulgaria; Bristol-Myers Squibb, Bahrain; Bristol-Myers Squibb, Brazil; Bristol-Myers Squibb, Switzerland; Bristol-Myers Squibb, China; Bristol-Myers Squibb, Germany; Bristol-Myers Squibb, Denmark; Bristol-Myers Squibb, Finland; Bristol-Myers Squibb, United Kingdom; Bristol-Myers Squibb, Greece; Bristol-Myers Squibb, Indonesia; Bristol-Myers Squibb, Ireland; Bristol-Myers Squibb, India; Bristol-Myers Squibb, Luxembourg; Bristol-Myers Squibb, Norway; Bristol-Myers Squibb, New Zealand; Bristol-Myers Squibb, Oman; Bristol-Myers Squibb, Pakistan; Bristol-Myers Squibb, Portugal; Bristol-Myers Squibb, Sweden; Bristol-Myers Squibb, Singapore; Bristol-Myers Squibb, Slovakia; Bristol-Myers Squibb, Taiwan; Bristol-Myers Squibb, United States; Bristol-Myers Squibb, Venezuela; Bristol-Myers Squibb, South Africa; Eisai, Japan; Elan, United States; Merck, Colombia; Merck, Peru; P & D, Malta; Sanofi-Aventis, France; Shanghai Pharma Group, China
  • Azenam
    Aristo, India
  • Aztram
    Shanxi C & Y, Philippines
  • Aztreo
    Zydus Cadila, India
  • Aztreonam Bedford (pediatric)
    Bedford, United States
  • Aztreonam Norgreen
    Norgreen, Argentina
  • Aztreonam Richet
    Richet, Argentina
  • Aztreonam Richet (Aztreonam and Arginine)
    Richet, Dominican Republic; Richet, Guatemala; Richet, Honduras; Richet, Panama
  • Aztreonam
    APP, United States; Farmalogica, Colombia; Vitalis, Colombia; Vitalis, Peru; Vitalis, Venezuela
  • Bencipen
    AC Farma, Peru
  • Cayston
    Gilead, Canada; Gilead, Germany; Gilead, Lithuania; Gilead, Latvia; Gilead, Netherlands
  • Primbactam
    Menarini, Italy
  • Trezam
    Glenmark, India
  • Vebac
    Fahrenheit, Indonesia
  • Cayston
    Gilead, Austria; Gilead, Switzerland; Gilead, France; Gilead, United Kingdom; Gilead, United States

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide
(web3)